- 全部删除
您的购物车当前为空
Rivastigmine tartrate (SDZ-ENA 713) 是一种具有口服活性的、可透过血脑屏障的胆碱酯酶抑制剂,能够抑制丁酰胆碱酯酶和乙酰胆碱酯酶。它是一种拟副交感神经剂或胆碱能剂,用于研究轻度至中度阿尔茨海默氏型痴呆和帕金森氏病引起的痴呆。

Rivastigmine tartrate (SDZ-ENA 713) 是一种具有口服活性的、可透过血脑屏障的胆碱酯酶抑制剂,能够抑制丁酰胆碱酯酶和乙酰胆碱酯酶。它是一种拟副交感神经剂或胆碱能剂,用于研究轻度至中度阿尔茨海默氏型痴呆和帕金森氏病引起的痴呆。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | ¥ 198 | In stock | |
| 25 mg | ¥ 300 | In stock | |
| 50 mg | ¥ 497 | In stock | |
| 100 mg | ¥ 756 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 253 | In stock |
Rivastigmine tartrate 相关产品
| 产品描述 | Rivastigmine tartrate (SDZ-ENA 713) is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE. |
| 靶点活性 | AChR:5.5 μM |
| 别名 | 酒石酸卡巴拉汀, SDZ-ENA 713, ENA 713 |
| 分子量 | 400.43 |
| 分子式 | C14H22N2O2·C4H6O6 |
| CAS No. | 129101-54-8 |
| Smiles | O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 74 mg/mL (184.8 mM), Sonication is recommended. DMSO: 39 mg/mL (97.4 mM), Sonication is recommended. H2O: 73 mg/mL (182.3 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
DMSO/H2O/Ethanol
H2O/Ethanol
| |||||||||||||||||||||||||||||||||||||||||
评论内容